Eurofins to Acquire Element's Life Sciences Testing Business in North America

Eurofins Scientific, a leader in bioanalytical testing, has entered into an agreement to acquire Element Materials Technology’s Life Sciences Testing Services in North America. The deal is valued at $400 million, pending customary conditions and regulatory approvals, with an expected closure in the fourth quarter of 2026.

The acquisition includes a network of 27 laboratories providing Biopharma, Environmental, and Food testing services, employing roughly 750 staff and projected to generate over $150 million in revenue for 2026. This move will enhance Eurofins' presence in crucial US and Canadian regions where it has been less represented.

CEO Dr. Gilles Martin stated the integration will leverage Eurofins' existing technological infrastructure, promising improved customer service. This aligns with the company's strategy of expanding its core testing capabilities.